Daniel Friedman - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Daniel Friedman’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
img

Social media:

Past investments:

  • Empire Genomics
  • InFuse Holdings
  • LabConnect
  • Diagnostic BioSystems
  • Biolog, Inc.
  • Pluristyx, Inc.
  • PBS Biotech
  • Codex DNA
  • Precision Cell Systems
  • Axol Bioscience Ltd.
  • BioCision
  • Genomenon
  • seqWell
  • Rubicon Genomics
  • Avidien Technologies Incorporated
  • Halo Labs
  • Bioinformatics

Investor Profile

Daniel Friedman is a Venture Capital, Investment Bank, Private Equity Firm based in Washington, District of Columbia, United States with a diverse investment portfolio that includes companies such as Empire Genomics, InFuse Holdings, LabConnect, Diagnostic BioSystems, Biolog, Inc., Pluristyx, Inc., PBS Biotech, Codex DNA, Precision Cell Systems, Axol Bioscience Ltd., BioCision, Genomenon, seqWell, Rubicon Genomics, Avidien Technologies Incorporated, Halo Labs, Bioinformatics. Over time, Daniel Friedman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Daniel Friedman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Strategic Partnerships, Chemical, Life Science, Portfolio Management, Analytics, Venture Fundraising, Finance, Software, Manufacturing, Biotechnology, Market Research, Genomics, FinTech, Reviews and Recommendations, Capital Raising, Consulting, Mergers and Acquisitions, Health Diagnostics, Market Intelligence, Developer Tools, Professional Networking, Medical, Big Data, B2B, Financial Advisory, Advanced Materials, Cellular Therapy, Pharmaceuticals, Acquisitions may find it worthwhile to explore potential connections with Daniel Friedman, as their portfolio suggests a familiarity and interest in this area.

Understanding Daniel Friedman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today